The distribution of cerebrovascular amyloid in Alzheimer's disease varies with ApoE genotype
- PMID: 17089130
- DOI: 10.1007/s00401-006-0162-9
The distribution of cerebrovascular amyloid in Alzheimer's disease varies with ApoE genotype
Abstract
We performed a comparative study to assess cerebral amyloid angiopathy and ApoE genotype in cases of Alzheimer's disease (AD). Ten ApoE 3,3 and ten ApoE 4,4 AD brains, as well as ten normal control brains, were selected after matching for age, sex, and duration of disease. Sections of middle frontal and inferior parietal cortex including white matter sections were stained with an antibody against amyloid beta (Abeta), and extensive analysis of arteriolar Abeta deposition was performed using digital image analysis. Quantification of the staining revealed a larger cross-section of arteriolar walls occupied by Abeta in ApoE 4,4 and ApoE 3,3 AD subjects compared to controls. Our results show Abeta deposition in gray matter and white matter arterioles was predominantly found in ApoE 4,4 brains and, overall, Abeta deposition was greatest in these cases. This observation implies that there is greater vascular amyloid deposition (particularly in the white matter arterioles) in ApoE 4,4 AD individuals compared to ApoE 3,3 AD. These observations may give insight into the etiology behind the increased risk for AD associated with the ApoE-epsilon4 allele and the pathogenesis of vascular Abeta deposition.
Similar articles
-
Apolipoprotein E co-localizes with newly formed amyloid beta-protein (Abeta) deposits lacking immunoreactivity against N-terminal epitopes of Abeta in a genotype-dependent manner.Acta Neuropathol. 2005 Nov;110(5):459-71. doi: 10.1007/s00401-005-1053-1. Epub 2005 Sep 30. Acta Neuropathol. 2005. PMID: 16195918
-
APOE, vascular pathology, and the AD brain.Neurology. 2005 Jul 26;65(2):259-65. doi: 10.1212/01.wnl.0000168863.49053.4d. Neurology. 2005. PMID: 16043796
-
Caveolin-1 and -2 and their relationship to cerebral amyloid angiopathy in Alzheimer's disease.Neuropathol Appl Neurobiol. 2007 Jun;33(3):317-27. doi: 10.1111/j.1365-2990.2006.00815.x. Neuropathol Appl Neurobiol. 2007. PMID: 17493012
-
Apolipoprotein E, amyloid-beta, and blood-brain barrier permeability in Alzheimer disease.J Neuropathol Exp Neurol. 2008 Apr;67(4):261-70. doi: 10.1097/NEN.0b013e31816a0dc8. J Neuropathol Exp Neurol. 2008. PMID: 18379441 Review.
-
Greasing the wheels of Abeta clearance in Alzheimer's disease: the role of lipids and apolipoprotein E.Biofactors. 2009 May-Jun;35(3):239-48. doi: 10.1002/biof.37. Biofactors. 2009. PMID: 19472365 Review.
Cited by
-
Population studies of sporadic cerebral amyloid angiopathy and dementia: a systematic review.BMC Neurol. 2009 Jan 13;9:3. doi: 10.1186/1471-2377-9-3. BMC Neurol. 2009. PMID: 19144113 Free PMC article. Review.
-
Cerebral amyloid angiopathy in Lewy body disease.J Neural Transm (Vienna). 2008;115(3):473-82. doi: 10.1007/s00702-007-0856-8. Epub 2008 Feb 26. J Neural Transm (Vienna). 2008. PMID: 18301958
-
Temporal Characterization of the Amyloidogenic APPswe/PS1dE9;hAPOE4 Mouse Model of Alzheimer's Disease.Int J Mol Sci. 2024 May 25;25(11):5754. doi: 10.3390/ijms25115754. Int J Mol Sci. 2024. PMID: 38891941 Free PMC article.
-
Analysis of beta-amyloid (Abeta) deposition in the temporal lobe in Alzheimer's disease using Fourier (spectral) analysis.Neuropathol Appl Neurobiol. 2010 Apr;36(3):248-57. doi: 10.1111/j.1365-2990.2010.01071.x. Epub 2010 Jan 29. Neuropathol Appl Neurobiol. 2010. PMID: 20132489 Free PMC article.
-
Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.Acta Neuropathol. 2009 Jul;118(1):103-13. doi: 10.1007/s00401-009-0522-3. Epub 2009 Mar 25. Acta Neuropathol. 2009. PMID: 19319544 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
